1. Catalogs
  2. Koelis
  3. Focal Therapy & Active Surveillance

Focal Therapy & Active Surveillance

Focal Therapy & Active Surveillance

Focal Therapy & Active Surveillance

Product catalog summary
Introduction
KOELIS introduces innovative technologies for prostate cancer management, focusing on personalized treatment through advanced biopsy strategies. The document highlights the use of 3D TRUS and MRI-guided biopsies for active surveillance and focal therapy, aiming to improve accuracy and patient outcomes.
Focal Therapy and Active Surveillance
Focal therapy targets specific tumor areas to minimize morbidity while maintaining life expectancy. Traditional diagnostic tools fall short in precise patient selection and treatment planning. KOELIS devices enhance this process by providing a urological view of cancer extension through colored biopsy samples and MRI data, aiding in decision-making for sparing or focal treatment.
3D TRUS Guided Biopsy System
Active surveillance requires regular follow-up biopsies to monitor disease progression. Standard 2D TRUS biopsies lack the ability to track previous sample locations accurately. KOELIS' 3D TRUS system allows for precise guidance, mapping, and recording of biopsy samples, which can be reviewed and integrated with MRI data for comprehensive disease documentation and targeted interventions.
Technological Innovations
KOELIS employs automatic 3D image-based prostate tracking and elastic TRUS/MRI fusion to enhance biopsy planning and targeting. This technology supports meticulous patient selection, distinguishing between indolent and high-risk tumors, and facilitates alternative treatments to radical prostatectomy.
Testimonials
Medical professionals from various institutions praise KOELIS technology for its accuracy and effectiveness in cancer detection and treatment planning. The integration of multiparametric MRI with targeted biopsy is noted for its exceptional sensitivity and specificity.
Company Background
Founded in 2006, KOELIS is based in Grenoble, France, and collaborates with renowned universities and hospitals to innovate in prostate cancer imaging and management. The company is committed to developing personalized solutions that respect patients' quality of life.
See more

Catalog excerpts

Focal Therapy & Active Surveillance-1

PROSTATE BIOPSY STRATEGIES FOR ACTIVE SURVEILLANCE AND FOCAL THERAPY EASY 3D TRUS & MRI GUIDED BIOPSY

 Open the catalog to page 1
Focal Therapy & Active Surveillance-2

NEW TECHNOLOGY for personalized Management of prostate cancer Focal therapy Active surveillance Focal Therapy for prostate cancer aims at selectively ablating the detected tumor while minimizing morbidity without compromising life expectancy. However, standard diagnosis tools do not enable the urologist to perform precise and trustworthy patient selection, as well as intraoperative focal treatment planning. KOELIS’ devices display a urological view of the cancer extension using colored biopsy samples histology and MRI suspicions. 3D biopsy mapping registered with MRI findings can immediately...

 Open the catalog to page 2
Focal Therapy & Active Surveillance-3

Koelis technology KOELIS proposes innovative software technologies to face those challenges: KOELIS devices implement automatic 3D image-based prostate tracking and elastic TRUS/MRI fusion, to provide accurate biopsy planning, mapping and targeting that are the cornerstones of a controllable and repeatable patient management process. The increasing number of early-detected low-risk prostate cancer allows physicians to consider alternative treatments to radical prostatectomy. In that context, Active Surveillance and Focal Therapy concepts have been proposed in a view to effectively treat tumors...

 Open the catalog to page 3
Focal Therapy & Active Surveillance-4

PROMAP-US / PROMAP-MR / PROMAP-2L/ PROMAP-VM Accurate diagnosis for adapted treatment Quality management in patient diagnosis Thanks to full 3D ultrasound, biopsy can be guided and recorded in a 3D map. The road to focal therapy Thanks to elastic TRUS-MR fusion, MRI lesions can be targeted. The road to active surveillance Thanks to inter-series elastic fusion, 2 consecutive biopsy maps can be matched. Prostate volume measurement Thanks to elastic prostate contours, a measurement of prostate volume can be displayed.

 Open the catalog to page 4
Focal Therapy & Active Surveillance-5

TESTIMONIALS “ The team work implemented since 3 years around Koelis products has benefited to hundreds of early diagnosed patients. “ Dr Pierre Mozer, Pitié Salpêtrière Hospital, Paris - FRANCE “ As any region can now be targeted transrectally we can plan sparing or focal treatment to many patients. ” Dr Eduard Baco, Aker University Hospital, Oslo - NORWAY “ The combination of multiparametric MRI with Koelis targeted biopsy brings exceptional sensitivity and specificity in cancer detection and description, and may lead, in the repeat biopsy population, to new guidelines from screening to personalized...

 Open the catalog to page 5
Focal Therapy & Active Surveillance-6

“Health innovation as a passion.” KOELIS was founded in 2006 by two experts in Image Guided Surgery in order to address new challenges in urology. Based in Grenoble,in the French hightech valley, in a healthy and mountaineering environment, KOELIS team innovates every day in collaboration with world-known universities and hospitals. KOELIS 5, Avenue du Grand Sablon 38700 La Tronche (Grenoble) - France KOELIS Inc. USA 185 Alewife Brook Parkway Suite 410 Cambridge MA 02138 - USA +33 (0)476 637 588 [email protected] KoelisBx ©2015 KOELIS All Rights Reserved. Urostation Touch® is a medical device (class...

 Open the catalog to page 6

All Koelis catalogs and technical brochures

  1. TRINITY®

    6  Pages

Archived catalogs

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.